French real estate investment trust Gecimed has said that it will carry out a EUR 100 mln capital increase in order to finance various projects and reduce debt. Shareholders will receive a proposal allowing for their preferential subscription rights to be maintained, following approval of a prospectus by the French securities regulator (AMF), the company said in a press release.